HIV cure may lie in radioimmunotherapy
A new study suggests targeting HIV with radioimmunotherapy could eradicate HIV from infected
cells. If given in conjunction with highly active antiretroviral therapy, it may form the basis of a
cure.
Although highly active antiretroviral therapy (HAART) kills human immunodeficiency virus (HIV) in the bloodstream, it does not completely eliminate
it from the body because the virus can linger in infected cells and replicate.
Researchers from the Albert Einstein College of Medicine of Yeshiva University in New York presented their
findings at the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA)
in Chicago, IL, this week.
Study leader Ekaterina Dadachova, professor of radiology and of microbiology & immunology, says although
there has been enormous progress in HIV treatments that slow progression to AIDS, the search for a permanent
cure continues. She explains:
